Literature DB >> 1950480

The compensatory 'rebound' of reactive astrogliosis: glial fibrillary acidic protein immunohistochemical analysis of reactive astrogliosis after a puncture wound to the brain of rats with portocaval anastomosis.

K C Ma1, Z H Chang, H Shih, J H Zhu, J Y Wu.   

Abstract

This study was designed to compare the degree of reactive astrogliosis occurring around a puncture wound in the brain of normal rats and at different intervals after a similar puncture wound in rats with a portocaval anastomosis. The gliosis was evaluated by the number of astrocytes, the thickness of their processes and the intensity of the glial fibrillary acidic protein immunoreactivity. After the puncture wound in the brain of rats with a portocaval anastomosis, the gliosis varied at different intervals being: (1) decreased at 10 days, (2) markedly increased at 5 weeks and (3) significantly decreased at 8, 12, and 16 weeks. These findings suggest that 5 weeks after portocaval anastomosis, an active proliferation of the metabolically altered astrocytes occurs with heightened synthesis of glial fibrillary acidic protein in the period of adaptive compensation, the so-called compensatory 'rebound'. At 8 weeks or more after portocaval anastomosis, these altered astrocytes were considered to be in the phase of decompensation and incapable of maintaining the reactive response which occurred in normal rats. The compensatory rebound and decompensatory 'decline' illustrate the dynamic plasticity of the reactive astrogliosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1950480     DOI: 10.1007/bf00310926

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

2.  Astrocyte activation and fibrous gliosis: glial fibrillary acidic protein immunostaining of astrocytes following intraspinal cord grafting of fetal CNS tissue.

Authors:  L F Eng; P J Reier; J D Houle
Journal:  Prog Brain Res       Date:  1987       Impact factor: 2.453

3.  An experimental model for the study of hepatic encephalopathy.

Authors:  M D Norenberg; L W Lapham; F A Nichols; A G May
Journal:  Arch Neurol       Date:  1974-08

4.  The proliferation of astrocytes around a needle wound in the rat brain.

Authors:  J B Cavanagh
Journal:  J Anat       Date:  1970-05       Impact factor: 2.610

5.  Astroglial reaction in the gray matter lumbar segments after midthoracic transection of the adult rat spinal cord.

Authors:  C P Barrett; L Guth; E J Donati; J G Krikorian
Journal:  Exp Neurol       Date:  1981-08       Impact factor: 5.330

6.  Glial fibrillary acidic protein immunohistochemical study of Alzheimer I & II astrogliosis in Wilson's disease.

Authors:  K C Ma; Z R Ye; J Fang; J V Wu
Journal:  Acta Neurol Scand       Date:  1988-10       Impact factor: 3.209

7.  Glial fibrillary acidic protein in hepatic encephalopathy. An immunohistochemical study.

Authors:  R A Sobel; S J DeArmond; L S Forno; L F Eng
Journal:  J Neuropathol Exp Neurol       Date:  1981-11       Impact factor: 3.685

8.  Astrocytes of the brain synthesize interleukin 3-like factors.

Authors:  K Frei; S Bodmer; C Schwerdel; A Fontana
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder.

Authors:  M D Norenberg
Journal:  Lab Invest       Date:  1977-06       Impact factor: 5.662

10.  Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells.

Authors:  B Tedeschi; J N Barrett; R W Keane
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

View more
  2 in total

1.  Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents.

Authors:  Miles G Cunningham; Ryan P O'Connor; Sydney E Wong
Journal:  J Vis Exp       Date:  2008-03-17       Impact factor: 1.355

2.  Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition.

Authors:  Ana Agusti; Jennifer L Dziedzic; Vicente Hernandez-Rabaza; Tomas R Guilarte; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2013-12-04       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.